BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10208426)

  • 21. Ras blooms on sterile ground.
    Cook S; McCormick F
    Nature; 1994 Jun; 369(6479):361-2. PubMed ID: 8196762
    [No Abstract]   [Full Text] [Related]  

  • 22. Pathway- and expression level-dependent effects of oncogenic N-Ras: p27(Kip1) mislocalization by the Ral-GEF pathway and Erk-mediated interference with Smad signaling.
    Kfir S; Ehrlich M; Goldshmid A; Liu X; Kloog Y; Henis YI
    Mol Cell Biol; 2005 Sep; 25(18):8239-50. PubMed ID: 16135812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostacyclin derivatives prevent the fibrotic response to TGF-beta by inhibiting the Ras/MEK/ERK pathway.
    Stratton R; Rajkumar V; Ponticos M; Nichols B; Shiwen X; Black CM; Abraham DJ; Leask A
    FASEB J; 2002 Dec; 16(14):1949-51. PubMed ID: 12368229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of specific MEK-ERK cascade is necessary for TGFbeta signaling and crosstalk with PKA and PKC pathways in cultured rat articular chondrocytes.
    Hirota Y; Tsukazaki T; Yonekura A; Miyazaki Y; Osaki M; Shindo H; Yamashita S
    Osteoarthritis Cartilage; 2000 Jul; 8(4):241-7. PubMed ID: 10903877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Divergence of epidermal growth factor - transforming growth factor beta signaling in embryonic orofacial tissue.
    Bhattacherjee V; Greene RM; Michele Pisano M
    In Vitro Cell Dev Biol Anim; 2003; 39(5-6):257-61. PubMed ID: 12880367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-talk between bone morphogenetic protein 2 and leukemia inhibitory factor through ERK 1/2 and Smad1 in protection against doxorubicin-induced injury of cardiomyocytes.
    Izumi M; Masaki M; Hiramoto Y; Sugiyama S; Kuroda T; Terai K; Hori M; Kawase I; Hirota H
    J Mol Cell Cardiol; 2006 Feb; 40(2):224-33. PubMed ID: 16427075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A kinase-inactive type II TGFbeta receptor impairs BMP signaling in human breast cancer cells.
    Dumont N; Arteaga CL
    Biochem Biophys Res Commun; 2003 Jan; 301(1):108-12. PubMed ID: 12535648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BMP-induced growth suppression in colon cancer cells is mediated by p21WAF1 stabilization and modulated by RAS/ERK.
    Beck SE; Jung BH; Del Rosario E; Gomez J; Carethers JM
    Cell Signal; 2007 Jul; 19(7):1465-72. PubMed ID: 17317101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Receptor tyrosine kinases inhibit bone morphogenetic protein-Smad responsive promoter activity and differentiation of murine MC3T3-E1 osteoblast-like cells.
    Nakayama K; Tamura Y; Suzawa M; Harada S; Fukumoto S; Kato M; Miyazono K; Rodan GA; Takeuchi Y; Fujita T
    J Bone Miner Res; 2003 May; 18(5):827-35. PubMed ID: 12733721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Raf induces TGFbeta production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells.
    Lehmann K; Janda E; Pierreux CE; Rytömaa M; Schulze A; McMahon M; Hill CS; Beug H; Downward J
    Genes Dev; 2000 Oct; 14(20):2610-22. PubMed ID: 11040215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth inhibitory signalling by TGFbeta is blocked in Ras-transformed intestinal epithelial cells at a post-receptor locus.
    Jiang B; Zhang JS; Du J; Urrutia R; Barnard J
    Cell Signal; 2003 Jul; 15(7):699-708. PubMed ID: 12742230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RAS/ERK modulates TGFbeta-regulated PTEN expression in human pancreatic adenocarcinoma cells.
    Chow JY; Quach KT; Cabrera BL; Cabral JA; Beck SE; Carethers JM
    Carcinogenesis; 2007 Nov; 28(11):2321-7. PubMed ID: 17638924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TGFbeta-stimulated Smad1/5 phosphorylation requires the ALK5 L45 loop and mediates the pro-migratory TGFbeta switch.
    Liu IM; Schilling SH; Knouse KA; Choy L; Derynck R; Wang XF
    EMBO J; 2009 Jan; 28(2):88-98. PubMed ID: 19096363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The TGFβ receptor-interacting protein km23-1/DYNLRB1 plays an adaptor role in TGFβ1 autoinduction via its association with Ras.
    Jin Q; Ding W; Mulder KM
    J Biol Chem; 2012 Jul; 287(31):26453-63. PubMed ID: 22637579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ras-mediated suppression of TGFbetaRII expression in intestinal epithelial cells involves Raf-independent signaling.
    Bulus NM; Sheng HM; Sizemore N; Oldham SM; Barnett JV; Coffey RJ; Beauchamp DR; Barnard JA
    Neoplasia; 2000; 2(4):357-64. PubMed ID: 11005570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transforming Growth Factor {beta} Can Stimulate Smad1 Phosphorylation Independently of Bone Morphogenic Protein Receptors.
    Wrighton KH; Lin X; Yu PB; Feng XH
    J Biol Chem; 2009 Apr; 284(15):9755-63. PubMed ID: 19224917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maintenance of the Undifferentiated State in Myogenic Progenitor Cells by TGFβ Signaling is Smad Independent and Requires MEK Activation.
    Miyake T; Aziz A; McDermott JC
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32033454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attenuation of haptoglobin gene expression by TGFbeta requires the MAP kinase pathway.
    Yu SJ; Boudreau F; Désilets A; Houde M; Rivard N; Asselin C
    Biochem Biophys Res Commun; 1999 Jun; 259(3):544-9. PubMed ID: 10364455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p21 Ras as a governor of global gene expression.
    Abdellatif M; MacLellan WR; Schneider MD
    J Biol Chem; 1994 Jun; 269(22):15423-6. PubMed ID: 8195182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crosstalk between protein kinase C α and transforming growth factor β signaling mediated by Runx2 in intestinal epithelial cells.
    Li X; Kaur N; Albahrani M; Karpf AR; Black AR; Black JD
    J Biol Chem; 2023 Apr; 299(4):103017. PubMed ID: 36791912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.